Publications by authors named "Emma Killick"

Claim this Profile
B
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.
Sibel Saya, Emma Killick, Sarah Thomas, Natalie Taylor, Elizabeth K Bancroft

Fam Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
Kate A McBride, Mandy L Ballinger, Timothy E Schlub, Mary-Anne Young, Martin H N Tattersall, Emma Killick

Fam Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Emma Killick

Eur Urol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere length shows no association with BRCA1 and BRCA2 mutation status.
Emma Killick, Malgorzata Tymrakiewicz, Clara Cieza-Borrella, Paula Smith, Deborah J Thompson

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins.
Swethajit Biswas, Emma Killick, Aart G Jochemsen, John Lunec

Expert Opin Investig Drugs· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Li-Fraumeni syndrome: cancer risk assessment and clinical management.
Kate A McBride, Mandy L Ballinger, Emma Killick, Judy Kirk, Martin H N Tattersall

Nat Rev Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.
Emma Killick, Richard Morgan, Francesca Launchbury, Elizabeth Bancroft, Elizabeth Page

Sci Rep· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis